Last updated on January 2017

Vaginal dryness


Brief description of study

Vaginal dryness

Detailed Study Description

A randomized, double-blinded, placebo-controlled, parallel design, multiple site study to evaluate the therapeutic equivalence of Estradiol vaginal cream USP, 0.01% (TEVA Pharmaceuticals, USA) to Estrace Estradiol vaginal cream, USP, 0.01% (Warner Chilcott) in treatment of atrophic vaginitis.

Clinical Study Identifier: TX147260

Contact Investigators or Research Sites near you

Start Over

Iliana Rodriguez

Northern California Research
Sacramento, CA USA
  Connect »